Denali shareholders elect directors, ratify auditor, approve executive compensation

Denali Therapeutics Inc.

Three Class I directors elected: Jay Flatley (108.1M for), Mac Tessier-Lavigne (82.2M for), Nancy Thornberry (108.3M for).
Ernst & Young ratified as auditor for FY2024 with 118.0M for, 297k against.
Say-on-pay advisory vote passed with 101.6M for, 8.6M against.
Meeting had 83.0% of outstanding shares present (118.3M of 142.5M shares).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.